The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic

Ureteral Calculi Clinical Trial

Official title:

The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02577146
• Other study ID #: 201506127
• Status: Completed
• Phase: N/A
• Start date: October 2015
• Est. completion date: December 2019

Study information

• Verified date: December 2019
• Source: Washington University School of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a single institution, prospective study to evaluate the prognostic significance of renal and bladder ultrasound with ureteral jet assessment and its utility to evaluate the spontaneous stone passage rate of ureteral stones.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 74
• Est. completion date: December 2019
• Est. primary completion date: May 7, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age 18 and older at the time of consent

• willing and able to sign consent

• CT diagnosis of ureteral stone with a stone burden less than or equal to 10mm

Exclusion Criteria:

• obstructed solitary kidney

• obstructed transplant kidney

• bilateral obstructed kidneys

• any condition or reason that, in the opinion of the treating physician, interferes with the patient's ability to participate or places the patient at undue risk.

Related Conditions & MeSH terms

• Calculi
• Renal Colic
• Ureteral Calculi
• Ureterolithiasis

Intervention

Device:
• renal and bladder ultrasound with ureteral jet assessment
The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.

Locations

Country	Name	City	State
United States	Washington University School of Medicine	Saint Louis	Missouri

Sponsors (2)

Lead Sponsor	Collaborator
Washington University School of Medicine	Midwest Stone Institute.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time in Days From Diagnosis to Stone Passage.	Number of days that have elapsed from date of diagnosis to date of stone passage or intervention to maximum observation time (42 days).	42 days
Secondary	The Number of Cases With Concordant Treatment Recommendations Based on the Ultrasound and CT Scan.		42 days